SIGMA RECEPTOR-BINDING AGENT

PROBLEM TO BE SOLVED: To prepare a sigma receptor-binding pharmaceutincal agent highly effective in antagonism or pungency to a sigma receptor, having safety and useful as a preventive, therapeutical and ameliorative agent, etc., for schizophrenia and aporioneurosis by including a specific benzylpip...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: YAMANISHI YOSHIHARU, SENAGA MASAHIRO, SUGIMOTO HACHIRO, IIMURA YOICHI
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator YAMANISHI YOSHIHARU
SENAGA MASAHIRO
SUGIMOTO HACHIRO
IIMURA YOICHI
description PROBLEM TO BE SOLVED: To prepare a sigma receptor-binding pharmaceutincal agent highly effective in antagonism or pungency to a sigma receptor, having safety and useful as a preventive, therapeutical and ameliorative agent, etc., for schizophrenia and aporioneurosis by including a specific benzylpiperidine derivative as an active component. SOLUTION: This pharmaceutical agent is prepared by including a benzylpiperidine of formula I [the bond of formula II is a single or double bond; R is an atomic group of formula III or the like; R is H or a lower alkoxy; (n) is 0-4] or its pharmacologically acceptable salt [e.g. 1-benzyl-4-(3,4- dihydro-4-oxoquinazolin-3-yl)piperidine, or the like] as an active component. The dose of the compound of formula I is pref. 1-500 mg/day and the pharmaceutical agent is oral administration, by intravenous injection, by intramuscular injection, by per rectum administration or by percutaneous administration.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JPH11349481A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JPH11349481A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JPH11349481A3</originalsourceid><addsrcrecordid>eNrjZJAJ9nT3dVQIcnV2DQjxD9J18vRz8fRzV3B0d_UL4WFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8V4BHoaGxiaWJhaGjsbEqAEAbpsg7w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SIGMA RECEPTOR-BINDING AGENT</title><source>esp@cenet</source><creator>YAMANISHI YOSHIHARU ; SENAGA MASAHIRO ; SUGIMOTO HACHIRO ; IIMURA YOICHI</creator><creatorcontrib>YAMANISHI YOSHIHARU ; SENAGA MASAHIRO ; SUGIMOTO HACHIRO ; IIMURA YOICHI</creatorcontrib><description>PROBLEM TO BE SOLVED: To prepare a sigma receptor-binding pharmaceutincal agent highly effective in antagonism or pungency to a sigma receptor, having safety and useful as a preventive, therapeutical and ameliorative agent, etc., for schizophrenia and aporioneurosis by including a specific benzylpiperidine derivative as an active component. SOLUTION: This pharmaceutical agent is prepared by including a benzylpiperidine of formula I [the bond of formula II is a single or double bond; R is an atomic group of formula III or the like; R is H or a lower alkoxy; (n) is 0-4] or its pharmacologically acceptable salt [e.g. 1-benzyl-4-(3,4- dihydro-4-oxoquinazolin-3-yl)piperidine, or the like] as an active component. The dose of the compound of formula I is pref. 1-500 mg/day and the pharmaceutical agent is oral administration, by intravenous injection, by intramuscular injection, by per rectum administration or by percutaneous administration.</description><edition>6</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1999</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19991221&amp;DB=EPODOC&amp;CC=JP&amp;NR=H11349481A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19991221&amp;DB=EPODOC&amp;CC=JP&amp;NR=H11349481A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YAMANISHI YOSHIHARU</creatorcontrib><creatorcontrib>SENAGA MASAHIRO</creatorcontrib><creatorcontrib>SUGIMOTO HACHIRO</creatorcontrib><creatorcontrib>IIMURA YOICHI</creatorcontrib><title>SIGMA RECEPTOR-BINDING AGENT</title><description>PROBLEM TO BE SOLVED: To prepare a sigma receptor-binding pharmaceutincal agent highly effective in antagonism or pungency to a sigma receptor, having safety and useful as a preventive, therapeutical and ameliorative agent, etc., for schizophrenia and aporioneurosis by including a specific benzylpiperidine derivative as an active component. SOLUTION: This pharmaceutical agent is prepared by including a benzylpiperidine of formula I [the bond of formula II is a single or double bond; R is an atomic group of formula III or the like; R is H or a lower alkoxy; (n) is 0-4] or its pharmacologically acceptable salt [e.g. 1-benzyl-4-(3,4- dihydro-4-oxoquinazolin-3-yl)piperidine, or the like] as an active component. The dose of the compound of formula I is pref. 1-500 mg/day and the pharmaceutical agent is oral administration, by intravenous injection, by intramuscular injection, by per rectum administration or by percutaneous administration.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1999</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAJ9nT3dVQIcnV2DQjxD9J18vRz8fRzV3B0d_UL4WFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8V4BHoaGxiaWJhaGjsbEqAEAbpsg7w</recordid><startdate>19991221</startdate><enddate>19991221</enddate><creator>YAMANISHI YOSHIHARU</creator><creator>SENAGA MASAHIRO</creator><creator>SUGIMOTO HACHIRO</creator><creator>IIMURA YOICHI</creator><scope>EVB</scope></search><sort><creationdate>19991221</creationdate><title>SIGMA RECEPTOR-BINDING AGENT</title><author>YAMANISHI YOSHIHARU ; SENAGA MASAHIRO ; SUGIMOTO HACHIRO ; IIMURA YOICHI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JPH11349481A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1999</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>YAMANISHI YOSHIHARU</creatorcontrib><creatorcontrib>SENAGA MASAHIRO</creatorcontrib><creatorcontrib>SUGIMOTO HACHIRO</creatorcontrib><creatorcontrib>IIMURA YOICHI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YAMANISHI YOSHIHARU</au><au>SENAGA MASAHIRO</au><au>SUGIMOTO HACHIRO</au><au>IIMURA YOICHI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SIGMA RECEPTOR-BINDING AGENT</title><date>1999-12-21</date><risdate>1999</risdate><abstract>PROBLEM TO BE SOLVED: To prepare a sigma receptor-binding pharmaceutincal agent highly effective in antagonism or pungency to a sigma receptor, having safety and useful as a preventive, therapeutical and ameliorative agent, etc., for schizophrenia and aporioneurosis by including a specific benzylpiperidine derivative as an active component. SOLUTION: This pharmaceutical agent is prepared by including a benzylpiperidine of formula I [the bond of formula II is a single or double bond; R is an atomic group of formula III or the like; R is H or a lower alkoxy; (n) is 0-4] or its pharmacologically acceptable salt [e.g. 1-benzyl-4-(3,4- dihydro-4-oxoquinazolin-3-yl)piperidine, or the like] as an active component. The dose of the compound of formula I is pref. 1-500 mg/day and the pharmaceutical agent is oral administration, by intravenous injection, by intramuscular injection, by per rectum administration or by percutaneous administration.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_JPH11349481A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title SIGMA RECEPTOR-BINDING AGENT
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T05%3A35%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YAMANISHI%20YOSHIHARU&rft.date=1999-12-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJPH11349481A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true